US Burden of Disorders Affecting the Nervous System - Part 1

US Burden of Disorders Affecting the Nervous System - Part 1

In part one of this two-part series, Dr. Stacey Clardy and Dr. John Ney break down the key message neurologists need to understand from this update and offer guidance on how to clearly convey it to patients.

Show citation:

Ney JP, Steinmetz JD, Anderson-Benge E, et al. US Burden of Disorders Affecting the Nervous System: From the Global Burden of Disease 2021 Study. JAMA Neurol. 2026;83(1):20-34. doi:10.1001/jamaneurol.2025.4470

Show transcript:

Dr. Stacey Clardy:

Hi, this is Stacey Clardy from the Salt Lake City VA in the University of Utah. I've been talking with John Ney from Yale about a global burden of disease analysis showing that disorders affecting nervous system health are the leading cause of disability in the United States. This is probably not too surprising to any neurologist, but very important that they rigorously went through to prove what we experience in clinics.

So John, for the Minute, when neurologists do hear it though, when they hear it out loud that more than half of the US population is affected by neurologic conditions, we're still a little skeptical. That's one in two, right? What's the single most important thing we need to understand about how that number was calculated and how to communicate it to our patients and our communities?

Dr. John Ney:

It's not just the sum of all conditions added up and then translated into the entire population. It's really looking at unique persons with a condition affecting the nervous system. And certainly our top two are tension type headache and migraine, but then we also get into diabetic neuropathy with 17 million individuals, stroke and Alzheimer's with six million and five million respectively. So individuals, unique persons may have more than one of these conditions, but 180 million or more persons in the United States or 54% of the population actually has at least one of these conditions.

Dr. Stacey Clardy:

So important that we understand this, these numbers. This matters to our patients when we're explaining it to them. Sometimes they feel alone, but this really also matters when we're talking about what we need for our patients as neurologists, more research, more resources.

If you want to learn more, listen to the full-length podcast. We get into the discussion, even breaking it down by states and conditions, and a bit more of the health economics and what informs these numbers. And also check out the paper in JAMA Neurology. It's titled US Burden of Disorders Affecting the Nervous System from the Global Burden of Disease 2021 Study.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(2010)

September 2026 President Spotlight: Our Next Step in Brain Health

September 2026 President Spotlight: Our Next Step in Brain Health

In the September episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss BrainHealth.com and the AAN's expanding brain health movement.  Stay informed by watching the Pres...

9 Syys 3min

Updates in Neuroinfectious Disease - Part 5

Updates in Neuroinfectious Disease - Part 5

In the fifth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss dexamethasone and listeria meningitis.

8 Syys 4min

Updates in Neuroinfectious Disease - Part 4

Updates in Neuroinfectious Disease - Part 4

In the fourth episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the use of dexamethasone in the treatment of pneumococcal meningitis.

7 Syys 5min

Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1

Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1

In the first installment of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss how emerging treatments for myasthenia gravis compare to one another.  Show citation:  McLaren NP, Rosati M, Z...

4 Syys 1min

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care

Dr. Jason Crowell and Ka-Ho Wong discuss national trends in Medicare reimbursement for inpatient neurologic care.  Show citation:  Wong KH, Castillo M, King J, et al. National Trends in Medicare Charg...

3 Syys 2min

Updates in Neuroinfectious Disease - Part 3

Updates in Neuroinfectious Disease - Part 3

In the third episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss HSV encephalitis and dexamethasone.

2 Syys 5min

Updates in Neuroinfectious Disease - Part 2

Updates in Neuroinfectious Disease - Part 2

In part two of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss pegivirus-associated encephalomyelitis.

1 Syys 5min

Updates in Neuroinfectious Disease - Part 1

Updates in Neuroinfectious Disease - Part 1

In part one of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss acute necrotizing encephalopathy.

31 Elo 4min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
aamukahvilla
rss-pitaisko-erota
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
meditaatiot-suomeksi
voi-hyvin-meditaatiot-2
rss-kuumilla-aalloilla
terapiassa
rss-pt-paahtio
paritellen
katilon-kahvitunti
rss-terapiaklubi
rss-sanelunpurku-podcast
rss-uplevel-by-sonja-hannus
rss-8-oppituntia-rohkeudesta
rss-vapaudu-voimaasi
rss-rentoudu-podcast-rentoutumiseen-hanna-viljanmaa
paaasia-podcast